MDxHealth S.A. (MDXH) Cash Flow Statement

The consistent gap between net income and operating cash flow suggests that the company's reported losses are exacerbated by non-cash charges and working capital volatility. Investors should monitor whether this disconnect narrows as the company scales, as current figures imply that operational efficiency remains secondary to aggressive commercial expansion.

While the shift toward positive FCF in the most recent quarter is a constructive signal, it appears largely driven by temporary working capital fluctuations rather than a structural change in the cost base. The lack of consistent, positive FCF generation warrants caution regarding the company's long-term self-sustainability.

The modest investment in physical infrastructure suggests that the company is not currently constrained by heavy equipment replacement cycles. However, this low capital intensity also implies that future growth will likely require continued high SG&A spending, which may further delay the path to meaningful cash flow generation.

This volatility suggests that the company's cash position is highly sensitive to the timing of third-party payer reimbursements and potential true-ups. Investors should interpret these swings as a sign of operational complexity in the revenue cycle, which may obscure the underlying health of the core diagnostic business.